Nothing Special   »   [go: up one dir, main page]

MX2010000953A - Microparticulas que comprenden pcl y uso de las misas. - Google Patents

Microparticulas que comprenden pcl y uso de las misas.

Info

Publication number
MX2010000953A
MX2010000953A MX2010000953A MX2010000953A MX2010000953A MX 2010000953 A MX2010000953 A MX 2010000953A MX 2010000953 A MX2010000953 A MX 2010000953A MX 2010000953 A MX2010000953 A MX 2010000953A MX 2010000953 A MX2010000953 A MX 2010000953A
Authority
MX
Mexico
Prior art keywords
microparticles
gel
treating
pcl
controlling
Prior art date
Application number
MX2010000953A
Other languages
English (en)
Inventor
Henderikus Super
Paul Willem Mijnen
Pieter Gerard Zijlstra
Dirk Wibe Grijpma
Original Assignee
Aqtis Ip Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38924473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010000953(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aqtis Ip Bv filed Critical Aqtis Ip Bv
Publication of MX2010000953A publication Critical patent/MX2010000953A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)

Abstract

La invención se refiere a un procedimiento para preparar micropartículas que comprenden PCL, a las micropartículas que se pueden obtener mediante dicho procedimiento, al del de esta manera obtenido y a varios usos del gel tales como para la preparación de un medicamento para tratar una anormalidad o desfiguración de la piel, y/o para controlar la función de la vejiga urinaria y/o para controlar el reflujo gástrico y/o para tratar disfunción eréctil y/o para tratar las cuerdas vocales. El gel también se puede utilizar para aplicaciones cosméticas.
MX2010000953A 2007-07-26 2008-07-23 Microparticulas que comprenden pcl y uso de las misas. MX2010000953A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95205607P 2007-07-26 2007-07-26
EP07113251 2007-07-26
PCT/NL2008/050506 WO2009014441A2 (en) 2007-07-26 2008-07-23 Microparticles comprising pcl and uses thereof

Publications (1)

Publication Number Publication Date
MX2010000953A true MX2010000953A (es) 2010-07-06

Family

ID=38924473

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010000953A MX2010000953A (es) 2007-07-26 2008-07-23 Microparticulas que comprenden pcl y uso de las misas.

Country Status (18)

Country Link
US (3) US8795694B2 (es)
EP (1) EP2170287B1 (es)
JP (2) JP5723152B2 (es)
KR (1) KR101517256B1 (es)
CN (2) CN104001209B (es)
AU (1) AU2008279879B2 (es)
BR (1) BRPI0814319A2 (es)
CA (1) CA2694852C (es)
DK (1) DK2170287T3 (es)
ES (1) ES2443537T3 (es)
IL (2) IL203536A (es)
MX (1) MX2010000953A (es)
NZ (1) NZ582813A (es)
PL (1) PL2170287T3 (es)
PT (1) PT2170287E (es)
SI (1) SI2170287T1 (es)
UA (1) UA97988C2 (es)
WO (1) WO2009014441A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010000953A (es) * 2007-07-26 2010-07-06 Aqtis Ip Bv Microparticulas que comprenden pcl y uso de las misas.
EP2550958B1 (en) * 2009-08-05 2018-10-10 Pieris Pharmaceuticals GmbH Controlled release formulations of lipocalin muteins
KR101726559B1 (ko) * 2015-07-17 2017-04-26 (주)인벤티지랩 생분해성 고분자를 포함하는 마이크로파티클의 제조방법
WO2017014431A1 (ko) * 2015-07-17 2017-01-26 (주)인벤티지랩 생분해성 고분자를 포함하는 마이크로파티클의 제조방법
KR101942449B1 (ko) * 2016-12-13 2019-01-28 주식회사 삼양바이오팜 생분해성 고분자의 다공성 미립자, 및 이를 포함하는 고분자 필러
WO2018110792A1 (ko) * 2016-12-13 2018-06-21 주식회사 삼양바이오팜 생분해성 고분자의 다공성 미립자, 및 이를 포함하는 고분자 필러
EP3409301B1 (en) 2017-05-30 2021-02-17 Aqpha Ip B.V. Resorbing biodegradable medical and cosmetic composition
RU2660550C1 (ru) * 2017-06-28 2018-07-06 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ получения инъекционного резорбируемого имплантата на основе поликапролактона и мультипотентных стромальных клеток пупочного канатика
RU2749803C1 (ru) * 2018-01-10 2021-06-17 Джи2Джибио, Инк. Поликапролактоновый микросферный филлер, содержащий коллагеновый пептид, и способ его изготовления
JP2021511300A (ja) * 2018-01-10 2021-05-06 ジー２ジーバイオ インコーポレイテッドＧ２Ｇｂｉｏ， Ｉｎｃ． ビタミンｃを含有したポリカプロラクトン微粒球フィラーおよびその製造方法
CN110339397B (zh) * 2019-07-11 2021-12-21 山东省药学科学院 一种不含助悬剂的可注射皮肤填充剂及其制备方法和用途
CN110279887B (zh) * 2019-07-18 2021-12-14 王月玲 一种多用途光子冷凝胶及其制备方法
CN110327497A (zh) * 2019-07-31 2019-10-15 易浦润（上海）生物技术有限公司 一种含微球的注射用凝胶及其制备方法
KR102381291B1 (ko) 2019-10-08 2022-04-01 주식회사 메타바이오메드 폴리디옥사논계 필러용 미립구의 제조방법
CN111184909B (zh) * 2019-10-21 2022-08-09 湖北翎美生物科技有限公司 一种透明质酸缓释填充物及制备方法
CN111249524B (zh) * 2020-01-18 2020-12-08 南京医科大学附属口腔医院 用于骨组织再生的高孔隙率聚己内酯多孔微球支架及其制备方法
US11684874B2 (en) 2020-12-29 2023-06-27 Metal Industries Research & Development Centre Tangential flow filtration module and tangential flow filtration assembly
JP2024532067A (ja) * 2021-08-19 2024-09-05 ジャビル インク 再沈殿によりポリカプロラクトン粉末を製造する方法および積層造形におけるその後の使用
CN113694252A (zh) * 2021-08-30 2021-11-26 济南大学 一种软组织充填剂的聚己内酯微球及其制备方法
CN114146220B (zh) * 2022-02-10 2022-04-29 中国远大集团有限责任公司 一种包含无菌pcl微球的美容产品
CN115779144B (zh) * 2022-09-27 2024-07-19 成都奇璞生物科技有限公司 可降解微球及其制备方法、应用以及用于治疗压力性尿失禁的填充剂
CN117838921A (zh) * 2022-09-30 2024-04-09 欣可丽美学(杭州)医疗科技有限公司 一种聚己内酯微球预分散组合物及由其制备的聚己内酯注射用凝胶

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07196479A (ja) * 1994-01-04 1995-08-01 Unitika Ltd マイクロカプセルの製造法
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US20030157187A1 (en) 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
FR2764514B1 (fr) 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
WO2002058671A1 (en) * 2001-01-26 2002-08-01 Debio Recherche Pharmaceutique S.A. Burst free pharmaceutical microparticules
US7314636B2 (en) 2001-06-29 2008-01-01 Medgraft Microtech, Inc. Biodegradable injectable implants containing glycolic acid
KR20030077386A (ko) * 2002-03-25 2003-10-01 주식회사 큐리안 생분해성 중합체 미립구의 신규 치료용도
NL1021843C2 (nl) 2002-11-05 2004-05-07 Univ Twente Biomedische structuren van poly (1,3-trimethyleencarbonaat) (poly (TMC)).
WO2006002050A1 (en) 2004-06-15 2006-01-05 Encore Therapeutics, Inc. Phospholipid compositions and methods for their preparation and use
EP2012751A4 (en) * 2006-03-21 2010-11-24 Morehouse School Of Medicine NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
US9119902B2 (en) * 2006-06-22 2015-09-01 Ethicon, Inc. Semi-crystalline absorbable microspheres
CA2663589A1 (en) * 2006-10-06 2008-05-22 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
MX2010000953A (es) * 2007-07-26 2010-07-06 Aqtis Ip Bv Microparticulas que comprenden pcl y uso de las misas.

Also Published As

Publication number Publication date
NZ582813A (en) 2011-09-30
CN101842084B (zh) 2014-11-05
EP2170287A2 (en) 2010-04-07
CA2694852A1 (en) 2009-01-29
JP5965472B2 (ja) 2016-08-03
IL203536A (en) 2014-07-31
US8795694B2 (en) 2014-08-05
DK2170287T3 (da) 2014-02-10
IL233562A0 (en) 2014-08-31
KR20100065309A (ko) 2010-06-16
US20150004206A1 (en) 2015-01-01
CN104001209A (zh) 2014-08-27
BRPI0814319A2 (pt) 2017-05-23
US20220105038A1 (en) 2022-04-07
PT2170287E (pt) 2014-02-14
AU2008279879A1 (en) 2009-01-29
PL2170287T3 (pl) 2014-04-30
SI2170287T1 (sl) 2014-04-30
ES2443537T3 (es) 2014-02-19
JP2015110595A (ja) 2015-06-18
EP2170287B1 (en) 2013-11-06
KR101517256B1 (ko) 2015-05-07
CN104001209B (zh) 2017-04-12
AU2008279879A2 (en) 2010-02-18
JP2010534649A (ja) 2010-11-11
UA97988C2 (en) 2012-04-10
WO2009014441A2 (en) 2009-01-29
JP5723152B2 (ja) 2015-05-27
WO2009014441A3 (en) 2009-04-23
US11998638B2 (en) 2024-06-04
US20100215702A1 (en) 2010-08-26
AU2008279879B2 (en) 2014-02-13
CN101842084A (zh) 2010-09-22
CA2694852C (en) 2017-02-28

Similar Documents

Publication Publication Date Title
MX2010000953A (es) Microparticulas que comprenden pcl y uso de las misas.
AU2018284960A1 (en) AADC polynucleotides for the treatment of Parkinson's disease
WO2016073693A3 (en) Aadc polynucleotides for the treatment of parkinson's disease
WO2018151821A8 (en) ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
PH12016500866A1 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
EA201290498A1 (ru) Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения
MX2010007490A (es) Preparacion de derivados de sulfamida.
WO2009089635A9 (en) Treating neurodegenerative diseases with progranulin (pgrn)
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
PH12020551006A1 (en) Anti-alpha synuclein antibodies
MY150931A (en) Substituted oxazolidinones and their use
WO2008104590A3 (en) Novel dosage form
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
PH12020551007A1 (en) Anti-alpha-synuclein antibodies
SG179203A1 (en) Novel arylated camphenes, processes for their preparation and uses thereof
WO2009115252A3 (de) Substituierte pyrazolamide und ihre verwendung
WO2012175742A3 (en) Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
WO2008118792A3 (en) Gamma delta t cells and methods of treatment of interleukin-17 related conditions
CL2008001211A1 (es) Compuestos derivados de benzotriazolilfenol sililado; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento contra condiciones no deseadas de la piel tales como queratosis actinica, urticaria solar y eritema solar.
WO2019016597A3 (en) SYNTHETIC PROTEINS AND THEIR THERAPEUTIC USES
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
WO2014141169A3 (en) Novel anti-neurodegenerative natural compounds isolated from alpiniae oxyphyllae fructus and total synthesis theirof